These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

229 related items for PubMed ID: 23450660

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Pridopidine for the treatment of motor function in patients with Huntington's disease (MermaiHD): a phase 3, randomised, double-blind, placebo-controlled trial.
    de Yebenes JG, Landwehrmeyer B, Squitieri F, Reilmann R, Rosser A, Barker RA, Saft C, Magnet MK, Sword A, Rembratt A, Tedroff J, MermaiHD study investigators.
    Lancet Neurol; 2011 Dec; 10(12):1049-57. PubMed ID: 22071279
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Safety and Exploratory Efficacy at 36 Months in Open-HART, an Open-Label Extension Study of Pridopidine in Huntington's Disease.
    McGarry A, Kieburtz K, Abler V, Grachev ID, Gandhi S, Auinger P, Papapetropoulos S, Hayden M.
    J Huntingtons Dis; 2017 Dec; 6(3):189-199. PubMed ID: 28826192
    [Abstract] [Full Text] [Related]

  • 5. Safety, tolerability, and efficacy of PBT2 in Huntington's disease: a phase 2, randomised, double-blind, placebo-controlled trial.
    Huntington Study Group Reach2HD Investigators.
    Lancet Neurol; 2015 Jan; 14(1):39-47. PubMed ID: 25467848
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Riluzole in Huntington's disease: a 3-year, randomized controlled study.
    Landwehrmeyer GB, Dubois B, de Yébenes JG, Kremer B, Gaus W, Kraus PH, Przuntek H, Dib M, Doble A, Fischer W, Ludolph AC, European Huntington's Disease Initiative Study Group.
    Ann Neurol; 2007 Sep; 62(3):262-72. PubMed ID: 17702031
    [Abstract] [Full Text] [Related]

  • 8. Efficacy and safety of the dopaminergic stabilizer Pridopidine (ACR16) in patients with Huntington's disease.
    Lundin A, Dietrichs E, Haghighi S, Göller ML, Heiberg A, Loutfi G, Widner H, Wiktorin K, Wiklund L, Svenningsson A, Sonesson C, Waters N, Waters S, Tedroff J.
    Clin Neuropharmacol; 2010 Sep; 33(5):260-4. PubMed ID: 20616707
    [Abstract] [Full Text] [Related]

  • 9. A randomized, double-blind, placebo-controlled study of latrepirdine in patients with mild to moderate Huntington disease.
    HORIZON Investigators of the Huntington Study Group and European Huntington's Disease Network.
    JAMA Neurol; 2013 Jan; 70(1):25-33. PubMed ID: 23108692
    [Abstract] [Full Text] [Related]

  • 10. A randomized, double-blind, placebo-controlled study of the efficacy and safety of donepezil in patients with Alzheimer's disease in the nursing home setting.
    Tariot PN, Cummings JL, Katz IR, Mintzer J, Perdomo CA, Schwam EM, Whalen E.
    J Am Geriatr Soc; 2001 Dec; 49(12):1590-9. PubMed ID: 11843990
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Effects of Pridopidine on Functional Capacity in Early-Stage Participants from the PRIDE-HD Study.
    McGarry A, Leinonen M, Kieburtz K, Geva M, Olanow CW, Hayden M.
    J Huntingtons Dis; 2020 Dec; 9(4):371-380. PubMed ID: 33164941
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. A pilot study using nabilone for symptomatic treatment in Huntington's disease.
    Curtis A, Mitchell I, Patel S, Ives N, Rickards H.
    Mov Disord; 2009 Nov 15; 24(15):2254-9. PubMed ID: 19845035
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. The Efficacy and Safety of Pridopidine on Treatment of Patients with Huntington's Disease: A Systematic Review and Meta-Analysis.
    Asla MM, Nawar AA, Abdelsalam A, Elsayed E, Rizk MA, Hussein MA, Kamel WA.
    Mov Disord Clin Pract; 2022 Jan 15; 9(1):20-30. PubMed ID: 35005061
    [Abstract] [Full Text] [Related]

  • 18. Short-term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross-over trial.
    Vitale C, Marconi S, Di Maio L, De Michele G, Longo K, Bonavita V, Barone P.
    Mov Disord; 2007 Dec 15; 22(16):2359-64. PubMed ID: 17894335
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.